Biotechnology News and Research RSS Feed - Biotechnology News and Research

HMS study reveals key instigator of nerve cell damage in ALS patients

HMS study reveals key instigator of nerve cell damage in ALS patients

Scientists from Harvard Medical School have identified a key instigator of nerve cell damage in people with amyotrophic lateral sclerosis, or ALS, a progressive and incurable neurodegenerative disorder. [More]
Chris Molloy appointed new CEO of Medicines Discovery Catapult

Chris Molloy appointed new CEO of Medicines Discovery Catapult

The Medicines Discovery Catapult has appointed its first Chief Executive Officer. Chris Molloy, who has more than 25 years’ experience in the international life science industry, will lead the MDC in developing new approaches for the discovery and early development of new medicines. [More]
Researchers investigate link between diet, obesity-linked Type 2 diabetes, and spinal disc degeneration

Researchers investigate link between diet, obesity-linked Type 2 diabetes, and spinal disc degeneration

Can a diet high in processed fat and sugar and Type 2 diabetes cause degeneration of intervertebral discs in the spine? If so, what is happening, and can it be prevented? As part of an ongoing collaboration between Rensselaer Polytechnic Institute and the Icahn School of Medicine at Mount Sinai - a partnership that draws upon the expertise of both schools to address significant health problems - researchers hope to answer those questions by investigating the link between diet, obesity-linked Type 2 diabetes, and intervertebral disc degeneration. [More]
Genekam develops first therapeutic molecule candidate for Zika viruses

Genekam develops first therapeutic molecule candidate for Zika viruses

GenekamBiotechnology AG, which developed the first test for Zika virus detection in January 2016, has developed as one of first company in the world the therapeutic molecule candidate for Zika viruses, which is likely to be the first potential candidate for Zika-virus therapy. [More]
Fruit fly models may help scientists understand underlying mechanism of HPV-induced cancer

Fruit fly models may help scientists understand underlying mechanism of HPV-induced cancer

Human papillomavirus (HPV) is one of the most common sexually transmitted infections in the United States and has been identified as a primary cause of cervical cancer in women. [More]
Novel marine natural product appears to reduce pancreatic tumor size

Novel marine natural product appears to reduce pancreatic tumor size

Scientists at Florida Atlantic University's Harbor Branch Oceanographic Institute found that a deep-water marine sponge collected off of Fort Lauderdale's coast contains leiodermatolide, a natural product that has the ability to inhibit the growth of cancer cells as well as block cancer cells from dividing using extremely low concentrations of the compound. [More]
New ATA recommendations offer guidance for managing all forms of thyrotoxicosis

New ATA recommendations offer guidance for managing all forms of thyrotoxicosis

New evidence-based recommendations from the American Thyroid Association provide guidance to clinicians in the management of patients with all forms of thyrotoxicosis (excessively high thyroid hormone activity), including hyperthyroidism. [More]
Ingenza celebrates success in securing EU H2020 SME Instrument support for SYNBIOMAN project

Ingenza celebrates success in securing EU H2020 SME Instrument support for SYNBIOMAN project

Ingenza is pleased to announce it has successfully applied for EU H2020 SME Instrument funding of €50,000 for Phase 1 of its innovative SYNBIOMAN project, allowing the company to forge ahead with the development of this novel synthetic biology-driven biomanufacturing platform. Successful completion of the Phase 1 study could open the door to additional funding for Phase 2, valued at €2.5 million. [More]
INTEGRA launches new version of popular pipette range with motorized tip spacing technology

INTEGRA launches new version of popular pipette range with motorized tip spacing technology

INTEGRA announces a new generation version of its popular VOYAGER pipette range that features unique motorized tip spacing technology. [More]
Scientists develop novel method to widen usage of blood in biomarker discovery and analysis

Scientists develop novel method to widen usage of blood in biomarker discovery and analysis

Scientists at Karolinska Institutet in collaboration with Estonian Competence Centre on Health Technologies have developed a new gene expression analysis method to widen the usage of blood in biomarker discovery and analysis. Their paper is published in the journal Scientific Reports. [More]
Could nanotechnology turn the cancer cell suicide switch back on? An interview with Professor Dipanjan Pan

Could nanotechnology turn the cancer cell suicide switch back on? An interview with Professor Dipanjan Pan

Before I explain the discovery, I would take a step back and explain an interesting event that takes place in the cancer cells. Normal cells follow a rapid and irreversible process to efficiently eradicate dysfunctional cells. This is a natural process by which damaged cells commit ‘suicide’. This process is known as apoptosis or programmed cell death. [More]
New model of Williams syndrome may shed light on neurobiology of the human social brain

New model of Williams syndrome may shed light on neurobiology of the human social brain

In a study spanning molecular genetics, stem cells and the sciences of both brain and behavior, researchers at University of California San Diego, with colleagues at the Salk Institute for Biological Studies and elsewhere, have created a neurodevelopmental model of a rare genetic disorder that may provide new insights into the underlying neurobiology of the human social brain. [More]
Mayo Clinic launches new blood test that measures plasma ceramides to predict risk for heart disease

Mayo Clinic launches new blood test that measures plasma ceramides to predict risk for heart disease

Mayo Clinic has launched a new type of blood test that will be used to predict adverse cardiovascular events in patients with progressing coronary artery disease (CAD). [More]
Sharing of patients' stem cells could boost bipolar disorder research

Sharing of patients' stem cells could boost bipolar disorder research

Stem cells from patients with bipolar disorder are being made available to scientists around the world to boost research into the condition. [More]
Wistar scientists discover novel mechanism that helps tumors adapt to hypoxia

Wistar scientists discover novel mechanism that helps tumors adapt to hypoxia

One of the many reasons tumors are so difficult to treat is that they are able to adapt whenever they are exposed to unfavorable conditions. [More]
Oncolytic virotherapy medicine shows positive treatment outcomes in late-stage cancer patients

Oncolytic virotherapy medicine shows positive treatment outcomes in late-stage cancer patients

The surprisingly positive treatment outcomes using Rigvir virotherapy for late stages cancer patients were recently published. [More]
Study shows striking differences in white matter volume between obese individuals and lean people

Study shows striking differences in white matter volume between obese individuals and lean people

From middle-age, the brains of obese individuals display differences in white matter similar to those in lean individuals ten years their senior, according to new research led by the University of Cambridge. [More]
Scientists engineer therapeutic system with two arms to get better hold on cancer target

Scientists engineer therapeutic system with two arms to get better hold on cancer target

Scientists have engineered a sort of biological barbell that can get inside cancer cells and do damage to two proteins that work independently and together to enable cancer's survival and spread. [More]
Next-generation sequencing to evaluate cell-free DNA yields more accurate results in diagnosis of MDS

Next-generation sequencing to evaluate cell-free DNA yields more accurate results in diagnosis of MDS

Using next-generation sequencing (NGS) methods to analyze cell-free DNA in the blood of patients with myelodysplastic syndrome (MDS) yields more accurate results than the current standard approach of Sanger sequencing. [More]
Bio-Rad expands product line by launching two human recombinant antigens

Bio-Rad expands product line by launching two human recombinant antigens

Bio-Rad Laboratories, Inc., a global provider of life science research and clinical diagnostic products, today announced the launch of two human recombinant antigens, expanding the company's portfolio of Critical Raw Materials for the in vitro diagnostics market. [More]
Advertisement
Advertisement